Epidermal Growth Factor Receptor Inhibition Strategies in Oncology

Endocrine-Related Cancer - United Kingdom
doi 10.1677/erc.1.00600
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Microtubule Inhibition Causes Epidermal Growth Factor Receptor Inactivation in Oesophageal Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2012English

Desensitization by Different Strategies of Epidermal Growth Factor Receptor and ErbB4

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2014English

Protein Expression Signatures for Inhibition of Epidermal Growth Factor Receptor-Mediated Signaling

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2011English

Strategies for Molecular Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase in Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

Epidermal Growth Factor Receptor in Human Glioma

Journal of Neurosurgery
SurgeryNeurology
1989English

BRAF; Epidermal Growth Factor Receptor (EGFR)

Science-Business eXchange
2012English

Pertuzumab Increases Epidermal Growth Factor Receptor Down-Regulation by Counteracting Epidermal Growth Factor Receptor-ErbB2 Heterodimerization

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: The Evolving Role of Individualized Therapy

Cancer and Metastasis Reviews
Cancer ResearchOncology
2010English

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers

Clinical Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy